View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Zapp EV Announces Reverse Stock Split

Zapp EV Announces Reverse Stock Split LONDON, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ZAPP) (“Zapp EV” or the “Company”), owner of “Zapp”, the British electric vehicle brand on a mission to revolutionize personal urban mobility, today announced that its shareholders approved at the Company’s annual general meeting on April 11, 2024, and that the Company will effect, a consolidation of its authorized share capital at a ratio of 1-for-20 (the “Reverse Stock Split”), in order that the share capital of the Company be amended from US$50,000 divided into 500,000,000 ordinary shares of a no...

 PRESS RELEASE

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

Rhythm Pharmaceuticals Announces New Employment Inducement Grants BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare neuroendocrine diseases, today announced that on April 11, 2024, the Compensation Committee of Rhythm’s board of directors granted inducement equity grants covering an aggregate of 31,220 shares of its common stock to eight new employees, consisting of inducement stock options to purchase an aggregate of 16,480 s...

 PRESS RELEASE

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Ne...

TScan Therapeutics Provides Clinical Pipeline Update and Highlights Near-Term Priorities Over 40 solid tumor patients have completed all biomarker testing in the screening protocol; ~60% of these patients qualify for at least one TCR-T in the ImmunoBank and ~30% are eligible for multiplex therapy Patients identified across all six TCR-T cohorts in solid tumor program with dosing of first three expected in early May All eight patients in the heme program treated with TSC-100 or TSC-101 remain relapse-free with no detectable cancer to date; median follow-up of >10 months WALTHAM, Mass., Ap...

 PRESS RELEASE

Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelinat...

Evidence for Clene’s CNM-Au8® as a Treatment for Repair and Remyelination in Multiple Sclerosis Presented in the Emerging Science Session at the 2024 American Academy of Neurology Annual Meeting Long term extension of the Phase 2 VISIONARY-MS clinical trial of CNM-Au8 demonstrated significant evidence of repair and remyelination across multiple paraclinical endpoints (change from original baseline, p

 PRESS RELEASE

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results...

Kiniksa Pharmaceuticals to Report First Quarter 2024 Financial Results on April 23, 2024 HAMILTON, Bermuda, April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, April 23, 2024 at 8:30 a.m. Eastern Time to report its first quarter 2024 financial results and recent portfolio execution. A live webcast will be accessible through the Investors & Media section of the company’s website at . Individuals interested in participating in the call via telephone may register . Upon registration, all telephone participants w...

 PRESS RELEASE

Freehold Royalties Ltd. Declares Dividend for April 2024

Freehold Royalties Ltd. Declares Dividend for April 2024 CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) --  Freehold Royalties Ltd. (Freehold) (TSX: FRU) announces that its Board of Directors has declared a dividend of Cdn. $0.09 per common share to be paid on May 15, 2024 to shareholders of record on April 30, 2024. These dividends are designated as “eligible dividends” for Canadian income tax purposes. Freehold’s focus is on acquiring and managing oil and gas royalties. Freehold’s common shares trade on the Toronto Stock Exchange in Canada under the symbol FRU. For further informa...

 PRESS RELEASE

Hancock Whitney Reports First Quarter 2024 EPS of $1.24

GULFPORT, Miss.--(BUSINESS WIRE)-- (Nasdaq: HWC) today announced its financial results for the first quarter of 2024. Net income for the first quarter of 2024 totaled $108.6 million, or $1.24 per diluted common share (EPS), compared to $50.6 million, or $0.58 per diluted common share, in the fourth quarter of 2023. The first quarter of 2024 included a $3.8 million charge, or $0.04 per diluted common share, of a supplemental disclosure item, related to a revision to the FDIC Special Assessment. The fourth quarter of 2023 included a net charge of $75.4 million, or $0.68 per diluted share after-...

 PRESS RELEASE

Heartland BancCorp Earns $5.1 Million, or $2.51 per Diluted Share, in ...

Heartland BancCorp Earns $5.1 Million, or $2.51 per Diluted Share, in the First Quarter of 2024; Declares Quarterly Cash Dividend of $0.759 per Share WHITEHALL, Ohio, April 16, 2024 (GLOBE NEWSWIRE) -- Heartland BancCorp (“Heartland” and “the Company”) (OTCQX: HLAN), parent company of Heartland Bank (“Bank”), today reported net income increased 14.2% to $5.1 million, or $2.51 per diluted share, in the first quarter of 2024, compared to $4.5 million, or $2.19 per diluted share, in the first quarter of 2023, and decreased 3.9% compared to $5.3 million, or $2.61 per diluted share, in the pre...

 PRESS RELEASE

Symbotic Announces Date for Reporting Second Quarter Fiscal 2024 Finan...

Symbotic Announces Date for Reporting Second Quarter Fiscal 2024 Financial Results WILMINGTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ), a leader in A.I.-enabled robotics technology for the supply chain, today announced it will release second quarter fiscal 2024 financial results after the market close on Monday, May 6, 2024. The press release will also be available on the Symbotic Investor Relations website: . The company will host a live webcast to discuss its financial results for the quarter at 5:00 p.m. ET on the same date. To listen to the live webcast, register at fo...

 PRESS RELEASE

Alaris Equity Partners Announces the Redemption of Brown & Settle

Alaris Equity Partners Announces the Redemption of Brown & Settle NOT FOR DISTRIBUTION IN THE UNITED STATES.FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAW. CALGARY, Alberta, April 16, 2024 (GLOBE NEWSWIRE) -- Alaris Equity Partners Income Trust (the "Trust" and, collectively with its subsidiaries, "Alaris") (TSX: AD.UN) is pleased to announce the redemption of Alaris' interest in Brown & Settle Investments, LLC ("B&S"), which closed on April 12, 2024, and resulted in gross proceeds to Alaris of US$71.5 million (CAD$97.8 million)...

Moody's Ratings assigns definitive ratings to Tricon Residential 2024-...

Moody's Ratings has assigned definitive ratings to four classes of single-family rental (SFR) securities issued by Tricon Residential 2024-SFR1 Trust, and sponsored by SFR JV-HD LP, a joint venture among Tricon Residential Inc., a residential real estate company, GIC, a sovereign wealth fund, and Pa...

Town of Millis, MA: Update to credit analysis

Our credit view highlighting the town's strong economy, satisfactory financial position and manageable leverage and fixed costs.

Laurens County, SC: Update following upgrade to Aa2

Our credit view of the county, which includes a healthy financial position, moderate long-term liabilities, and an expanding local economy.

Village of Valley Stream, NY: Update to credit analysis following upgr...

Our credit view including the village's progress toward maintaining a stable financial position while balancing budget operations, as well as its healthy local economy and moderate leverage.

Moody's Ratings assigns Ba3 rating to Boels' new senior secured notes,...

Moody's Ratings has assigned a Ba3 instrument rating to Boels Topholding B.V.'s (Boels or the company) proposed €500 million backed senior secured notes due 2030. All other ratings, including the Ba3 Corporate Family Rating (CFR), the Ba3-PD Probability of Default Rating (PDR), Ba3 instrument rating...

Moody's Ratings downgrades Vandalia-Butler City School District, OH's ...

Moody's Ratings has downgraded Vandalia-Butler City School District, OH outstanding issuer, general obligation unlimited tax (GOULT), and limited tax (GOLT) backed debt ratings to A1 from Aa3. As of fiscal 2023, the district had approximately $41 million of debt outstanding. The downgrade to A1 is...

Bell Co. Water Control&Improvement Dist. 1, TX: Update to credit analy...

Our credit view of this issuer reflects its strong liquidity with a growing service area supported by institutional presence from Fort Cavazos, offset by its sizable debt profile.

ABGSC IT Research ... (+3)
  • ABGSC IT Research
  • Daniel Thorsson
  • Simon Granath
 PRESS RELEASE

Nokia Corporation: Repurchase of own shares on 16.04.2024

Nokia Corporation: Repurchase of own shares on 16.04.2024 Nokia CorporationStock Exchange Release16 April 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 16.04.2024 Espoo, Finland – On 16 April 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL557,6403.17CEUX--BATE--AQEU--TQEX--Total557,6403.17 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return u...

Moody's Ratings affirms Franklin Square Holding's Ba1 CFR; outlook sta...

Moody's Ratings has affirmed Franklin Square Holdings, L.P.'s ("FSH") Ba1 Corporate Family Rating (CFR) and Ba1-PD Probability of Default rating. Moody's Ratings also assigned a Ba1 rating to FSH's new $700mm senior secured term loan B due 2031 and $150mm senior secured revolving credit facility. Th...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch